Smear microscopy as surrogate for culture during follow up of pulmonary MDR-TB patients on DOTS plus treatment.

dc.contributor.authorSarin, R
dc.contributor.authorSingla, R
dc.contributor.authorVisalakshi, P
dc.contributor.authorJaiswal, A
dc.contributor.authorPuri, M M
dc.contributor.authorKhalid, U K
dc.contributor.authorMathuria, K
dc.contributor.authorSingla, N
dc.contributor.authorBehera, D
dc.contributor.authorSharma, P P
dc.date.accessioned2013-05-21T07:49:02Z
dc.date.available2013-05-21T07:49:02Z
dc.date.issued2010-07
dc.description.abstractBackground: DOTS Plus site at LRS Institute, New Delhi, covering 1.8 million population. Aims: To ascertain if sputum smear could be used as a surrogate for culture during intensive phase of treatment of MDRTB patients thereby enabling early shift from intensive phase to continuation phase, reducing the need for frequent cultures and saving time and cost in their management. Methods: The study is a retrospective analysis of 138 MDR-TB patients on DOTS Plus treatment whose sputum samples were simultaneously subjected to smear microscopy and culture, monthly during Intensive Phase and once in two months during Continuation Phase. Sputum results in the treatment card were supplemented from laboratory register, if required, and analyzed. Predictive values, sensitivity and specificity of smear were compared with culture results. Results: The Negative Predictive Value (NPV) of smear was high from the 3rd month onwards (above 91%), at four months 98% or more and approached 100% from eight months onwards. The specificity of smear test gradually increased during treatment and from five months onwards, it was above 90%. Conclusions: Considerable correlation was observed between sputum smear and culture during follow up of DOTS Plus treatment in the Intensive Phase. Accordingly, sputum smears can be recommended instead of culture.en_US
dc.identifier.citationSarin R, Singla R, Visalakshi P, Jaiswal A, Puri M M, Khalid U K, Mathuria K, Singla N, Behera D, Sharma P P. Smear microscopy as surrogate for culture during follow up of pulmonary MDR-TB patients on DOTS plus treatment. Indian Journal of Tuberculosis. 2010 Jul; 57(3): 134-140.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/146852
dc.language.isoenen_US
dc.source.urihttps://medind.nic.in/ibr/t10/i3/ibrt10i3p134.pdfen_US
dc.subjectSputum smearen_US
dc.subjectCultureen_US
dc.subjectMDR-TBen_US
dc.subjectDOTS Plusen_US
dc.titleSmear microscopy as surrogate for culture during follow up of pulmonary MDR-TB patients on DOTS plus treatment.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijt2010v57i3p134.pdf
Size:
135.88 KB
Format:
Adobe Portable Document Format
Description:
Journal article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: